New

Non-alcoholic Steatohepatitis Biomarkers Market

2021

Non-alcoholic Steatohepatitis Biomarkers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Serum biomarkers, Hepatic fibrosis biomarkers, Apoptosis biomarkers, Oxidative stress biomarkers, Others); Application (Pharmaceutical and CRO Industry, Hospitals, Diagnostic Labs, Academic Research Institutes) and Geography

| Report Code: TIPRE00023192 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Non-alcoholic Steatohepatitis Biomarkers Market 2028 By Type, Application and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Non-alcoholic steatohepatitis (NASH) is a type of severe fatty liver disease that is non-alcoholic fatty liver disease (NAFLD). NAFLD is a condition caused due to fat accumulation in the liver and the continuous fat deposition may cause liver inflammation and injury that is known as NASH. NASH can result in scarring of the liver, which is a potentially life-threatening condition known as cirrhosis. The symptoms includes easy bleeding and bruising, itchy skin, jaundice, loss of appetite, nausea, and many more. NASH is more prevalent in patients who are overweight or obese including diabetic, people with elevated cholesterol, inadequate nutrition, polycystic ovary syndrome, and hypothyroidism. Various innovative diagnostic tools are used for accurate diagnosis of the non-alcoholic steatohepatitis condition such as liver biopsy. However, due to high cost of this procedure, various companies have introduced biomarkers as a diagnostic tool for NASH patients such as serum biomarkers, biomarker panels, fibrosis biomarkers, imaging biomarkers, gene biomarkers, and oxidative stress biomarkers.

MARKET SCOPE

The "Global Non-Alcoholic Steatohepatitis Biomarkers Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the non-alcoholic steatohepatitis biomarkers market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading non-alcoholic steatohepatitis biomarkers market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global non-alcoholic steatohepatitis biomarkers market is segmented into serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers and others.
  •  On the basis of application, the market is segmented into pharmaceutical & CRO industry, hospitals, diagnostic labs and academic research institutes.

MARKET DYNAMICS
Drivers

  •   Rising prevalence of non-alcoholic steatohepatitis (NASH), growing patient pool suffering from diabetes and obesity is driving the non-alcoholic steatohepatitis biomarkers market.
  •   Increasing patient awareness, growing need for appropriate diagnostic methods and growing demand for noninvasive diagnostic instruments boosts the market growth.
  •   Growing technological advancements, increasing research and development activities and high prevalence of non-alcoholic fatty liver disease (NAFLD) fuel the market growth.
  •   Rising advancements in the healthcare infrastructure in developing economies propel the market growth.

Restraints

  •   Side effects of NASH therapeutics.
  •   Lack of advanced diagnostic testing for NAFLD.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The non-alcoholic steatohepatitis biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the non-alcoholic steatohepatitis biomarkers market in these regions.

IMPACT OF COVID-19 ON NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The outbreak of novel coronavirus pandemic impacted the growth of the market. It has created major roadblocks for companies which are operating in the non-alcoholic steatohepatitis (NASH) biomarkers market. Due to supply chain disruptions, business shutdown, country-wise lockdown the marketers faced a challenging situation. Companies should now focus on effective business strategies formulation and product diversification in order to overcome the challenges that has aroused during the global pandemic.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the non-alcoholic steatohepatitis biomarkers market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from non-alcoholic steatohepatitis biomarkers market are anticipated to have lucrative growth opportunities in the future with the rising demand for non-alcoholic steatohepatitis biomarkers in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the non-alcoholic steatohepatitis biomarkers market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  BioPredictive
  •  Cisbio
  •  Allergan
  •  NGM Biopharmaceuticals
  •  AstraZeneca
  •  Novartis AG
  •  Novo Nordisk A/S
  •  Pfizer, Inc.
  •  Siemens Healthineers
  •  Genfit

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Non-alcoholic Steatohepatitis Biomarkers Market - By Type
1.3.2 Non-alcoholic Steatohepatitis Biomarkers Market - By Application
1.3.3 Non-alcoholic Steatohepatitis Biomarkers Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET - GLOBAL MARKET ANALYSIS
6.1. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS - GLOBAL MARKET OVERVIEW
6.2. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SERUM BIOMARKERS
7.3.1. Overview
7.3.2. Serum biomarkers Market Forecast and Analysis
7.4. HEPATIC FIBROSIS BIOMARKERS
7.4.1. Overview
7.4.2. Hepatic fibrosis biomarkers Market Forecast and Analysis
7.5. APOPTOSIS BIOMARKERS
7.5.1. Overview
7.5.2. Apoptosis biomarkers Market Forecast and Analysis
7.6. OXIDATIVE STRESS BIOMARKERS
7.6.1. Overview
7.6.2. Oxidative stress biomarkers Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PHARMACEUTICAL AND CRO INDUSTRY
8.3.1. Overview
8.3.2. Pharmaceutical and CRO Industry Market Forecast and Analysis
8.4. HOSPITALS
8.4.1. Overview
8.4.2. Hospitals Market Forecast and Analysis
8.5. DIAGNOSTIC LABS
8.5.1. Overview
8.5.2. Diagnostic Labs Market Forecast and Analysis
8.6. ACADEMIC RESEARCH INSTITUTES
8.6.1. Overview
8.6.2. Academic Research Institutes Market Forecast and Analysis

9. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Non-alcoholic Steatohepatitis Biomarkers Market Overview
9.1.2 North America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis
9.1.3 North America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Type
9.1.4 North America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Application
9.1.5 North America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Non-alcoholic Steatohepatitis Biomarkers Market
9.1.5.1.1 Canada Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.1.5.1.2 Canada Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.1.5.2 Mexico Non-alcoholic Steatohepatitis Biomarkers Market
9.1.5.2.1 Mexico Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.1.5.2.2 Mexico Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.1.5.3 US Non-alcoholic Steatohepatitis Biomarkers Market
9.1.5.3.1 US Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.1.5.3.2 US Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.2. EUROPE
9.2.1 Europe Non-alcoholic Steatohepatitis Biomarkers Market Overview
9.2.2 Europe Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis
9.2.3 Europe Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Type
9.2.4 Europe Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Application
9.2.5 Europe Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Non-alcoholic Steatohepatitis Biomarkers Market
9.2.5.1.1 Germany Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.2.5.1.2 Germany Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.2.5.2 France Non-alcoholic Steatohepatitis Biomarkers Market
9.2.5.2.1 France Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.2.5.2.2 France Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.2.5.3 Italy Non-alcoholic Steatohepatitis Biomarkers Market
9.2.5.3.1 Italy Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.2.5.3.2 Italy Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.2.5.4 Spain Non-alcoholic Steatohepatitis Biomarkers Market
9.2.5.4.1 Spain Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.2.5.4.2 Spain Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.2.5.5 United Kingdom Non-alcoholic Steatohepatitis Biomarkers Market
9.2.5.5.1 United Kingdom Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.2.5.5.2 United Kingdom Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.2.5.6 Rest of Europe Non-alcoholic Steatohepatitis Biomarkers Market
9.2.5.6.1 Rest of Europe Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.2.5.6.2 Rest of Europe Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market Overview
9.3.2 Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis
9.3.3 Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Non-alcoholic Steatohepatitis Biomarkers Market
9.3.5.1.1 Australia Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.3.5.1.2 Australia Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.3.5.2 China Non-alcoholic Steatohepatitis Biomarkers Market
9.3.5.2.1 China Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.3.5.2.2 China Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.3.5.3 India Non-alcoholic Steatohepatitis Biomarkers Market
9.3.5.3.1 India Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.3.5.3.2 India Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.3.5.4 Japan Non-alcoholic Steatohepatitis Biomarkers Market
9.3.5.4.1 Japan Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.3.5.4.2 Japan Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.3.5.5 South Korea Non-alcoholic Steatohepatitis Biomarkers Market
9.3.5.5.1 South Korea Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.3.5.5.2 South Korea Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.3.5.6 Rest of Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market
9.3.5.6.1 Rest of Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.3.5.6.2 Rest of Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market Overview
9.4.2 Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis
9.4.3 Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Non-alcoholic Steatohepatitis Biomarkers Market
9.4.5.1.1 South Africa Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.4.5.1.2 South Africa Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.4.5.2 Saudi Arabia Non-alcoholic Steatohepatitis Biomarkers Market
9.4.5.2.1 Saudi Arabia Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.4.5.2.2 Saudi Arabia Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.4.5.3 U.A.E Non-alcoholic Steatohepatitis Biomarkers Market
9.4.5.3.1 U.A.E Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.4.5.3.2 U.A.E Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.4.5.4 Rest of Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market
9.4.5.4.1 Rest of Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.4.5.4.2 Rest of Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Non-alcoholic Steatohepatitis Biomarkers Market Overview
9.5.2 South and Central America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis
9.5.3 South and Central America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Type
9.5.4 South and Central America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Application
9.5.5 South and Central America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Non-alcoholic Steatohepatitis Biomarkers Market
9.5.5.1.1 Brazil Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.5.5.1.2 Brazil Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.5.5.2 Argentina Non-alcoholic Steatohepatitis Biomarkers Market
9.5.5.2.1 Argentina Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.5.5.2.2 Argentina Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.5.5.3 Rest of South and Central America Non-alcoholic Steatohepatitis Biomarkers Market
9.5.5.3.1 Rest of South and Central America Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.5.5.3.2 Rest of South and Central America Non-alcoholic Steatohepatitis Biomarkers Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET, KEY COMPANY PROFILES
11.1. BIOPREDICTIVE
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CISBIO
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ALLERGAN
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. NGM BIOPHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ASTRAZENECA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOVARTIS AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVO NORDISK A/S
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SIEMENS HEALTHINEERS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. GENFIT
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. BioPredictive
2. Cisbio
3. Allergan
4. NGM Biopharmaceuticals
5. AstraZeneca
6. Novartis AG
7. Novo Nordisk A/S
8. Pfizer, Inc.
9. Siemens Healthineers
10. Genfit
TIPRE00023192
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.